To view or add a comment, sign in "Health insurers are raising questions about the Trump administrations plan to cover obesity drugs in Medicare next year, casting doubt on whether enough insurers will sign on to the effort for it to launch as planned" NEW: UnitedHealth just cast doubt on the Trump administration's high-profile plan to cover obesity drugs in Medicare next year
And so we think about the same thing is true of diabetes, and we think about obesity now as in that same category
Differences in genes that affect GLP-1 receptor sensitivity and other appetite pathways can blunt the medication effect for some people
[Google Scholar] [PubMed] Hussain K, Salat MS, Ambreen G, Mughal A, Idrees S, Sohail M, et al
These effects are usually most pronounced when starting the medication or increasing the dose, and they often improve over time
Create a Restful Environment: Ensure your bedroom is dark, quiet, and cool